Skip to content

CTKB - Cytek Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cytek Biosciences Inc

CTKB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CTKBCytek Biosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $6.18
52-wk low: $3.28
Prev close: $4.87
Mkt cap: $610.9M
Fwd P/E: 370.4x
Beta: 1.17

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$113.8M

MI
Millennium
Israel Englander · Q2 2026 13F
$41.4M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in $0.03 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -39.0%
Forward P/E: 370.37
Market cap: $611M

Valuation

P/S2.96
P/B1.89

Quality

Operating margin-29.5%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CTKB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $610.92M
Beta: 1.17

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

3.0x

P/B

1.9x

Profit margin

-39.0%

Op margin

-29.5%

ROE

-23.0%

$3.6M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$3.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CTKB

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.09-$0.03

-$0.06 expected

Next report

What the street expects next

ROE

-23.0%

ROA-6.3%

Growth

Beta1.17